株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ブラジルの糖尿病市場の分析

Brazil Diabetes Market Report: 2019 - 2024

発行 IMARC Services Private Limited 商品コード 359376
出版日 ページ情報 英文 91 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
ブラジルの糖尿病市場の分析 Brazil Diabetes Market Report: 2019 - 2024
出版日: 2019年06月10日 ページ情報: 英文 91 Pages
概要

当レポートでは、ブラジル国内の糖尿病市場について分析し、現在の疫学的状況 (患者人口、有病率など) や背景事情、主な治療法、関連市場 (治療薬など) の推移と見通し、近年の市場の主な動き、競争環境などについて調査しております。

第1章 分析手法

第2章 エグゼクティブ・サマリー

第3章 糖尿病の概要

  • 糖尿病とは何か?
  • 糖尿病の診断・治療
  • 糖尿病の合併症

第4章 ブラジルの糖尿病市場の促進要因

第5章 ブラジル国内の糖尿病の疫学

  • 糖尿病の患者数と有病率
  • 患者数と有病率:種類別 (1型・2型糖尿病)
  • 患者数と有病率:地域別
  • 患者数と有病率:男女別
  • 患者数と有病率:年齢層別

第6章 ブラジルの糖尿病市場

  • 過去の市場動向
  • 市場の将来展望
  • 部門別の市場内訳
  • ブラジルの経口抗糖尿病薬市場
    • 過去の市場動向
    • クラス別の市場内訳
    • 主要企業の市場シェア
    • 市場の将来展望
  • ブラジルのインスリン市場

図表一覧

図表

List of Figures

  • Figure 1: The Impact of Diabetes in the Human Body
  • Figure 2: Diabetes Complications
  • Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2018 & 2024
  • Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 5: Brazil: Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 6: Brazil: Total Number of Diabetes Patients Forecast (in 000), 2019-2024
  • Figure 7: Brazil (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 8: Brazil (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 9: Brazil (Urban & Rural): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 10: Brazil (Urban & Rural): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 11: Brazil (Male & Female): Total Number of Diabetes Patients (in 000), 2011-2018
  • Figure 12: Brazil (Male & Female): Total Number of Diabetes Patients (in 000), 2019-2024
  • Figure 13: Brazil: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2011-2018
  • Figure 14: Brazil: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2019-2024
  • Figure 15: Brazil: Diabetes Drug Industry Overview
  • Figure 16: Brazil: Diabetes Drug Market: Sales Value (in Million US$), 2011-2018
  • Figure 17: Brazil: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Brazil: Diabetes Drug Market: SWOT Analysis
  • Figure 19: Brazil: Diabetes Drug Market: Value Chain Analysis
  • Figure 20: Brazil: Diabetes Drug Market: Porters Five Forces Analysis
  • Figure 21: Brazil: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2018
  • Figure 22: Brazil: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2019-2024
  • Figure 23: Brazil: Oral Antidiabetics Market: Sales Value (in Million US$), 2011-2018
  • Figure 24: Brazil: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011 & 2018
  • Figure 25: Brazil: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
  • Figure 26: Brazil: Oral Antidiabetics Market: Sales Value (in Million US$), 2019-2024
  • Figure 27: Brazil: Insulin Market: Sales Value (in Million US$), 2011-2018
  • Figure 28: Brazil: Breakup of Insulin Market by Class (in %), 2011 & 2018
  • Figure 29: Brazil: Insulin Market: Sales Share of Key Players (in %)
  • Figure 30: Brazil: Insulin Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Diagnosis of Diabetes
  • Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2018 & 2024
  • Table 3: Brazil: Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 4: Brazil (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 5: Brazil (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 6: Brazil (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2018 & 2024
  • Table 7: Brazil: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2018 & 2024
  • Table 8: Brazil: Diabetes Drug Market: Competitive Structure
目次
Product Code: SR1019B61_Report

IMARC's new report "Brazil Diabetes Market Report: 2019-2024" provides an analytical and statistical insight into the Brazil diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Brazil. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Brazil diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Brazil diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Brazil diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Brazil
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Brazil
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Brazil
  • Historical, current and future prevalence of diabetes among males and females in Brazil
  • Historical, current and future prevalence of diabetes among various age groups in Brazil
  • Historical, current and future diagnosis rates for diabetes in Brazil
  • Historical, current and future drug treatment rates for diabetes in Brazil

Comprehensive situation analysis of the Brazil Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Brazil
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Brazil Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Brazil
  • Performance of key classes
  • Performance of key players
  • Market outlook

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Diabetes Disease Overview

  • 5.1 What is Diabetes?
  • 5.2 Diabetes Diagnosis and Treatment
    • 5.2.1 Diagnosis
    • 5.2.2 Treatment
  • 5.3 Diabetes Complications

6 Brazil Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group

7 Brazil Diabetes Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Forecast
  • 7.4 SWOT Analysis
    • 7.4.1 Overview
    • 7.4.2 Strengths
    • 7.4.3 Weaknesses
    • 7.4.4 Opportunities
    • 7.4.5 Threats
  • 7.5 Value Chain Analysis
  • 7.6 Porter's Five Forces Analysis
    • 7.6.1 Overview
    • 7.6.2 Bargaining Power of Buyers
    • 7.6.3 Bargaining Power of Suppliers
    • 7.6.4 Degree of Competition
    • 7.6.5 Threat of New Entrants
    • 7.6.6 Threat of Substitutes
  • 7.7 Market Breakup by Segment
    • 7.7.1 Brazil Oral Antidiabetics Market
      • 7.7.1.1 Historical Market Trends
      • 7.7.1.2 Market Breakup by Class
      • 7.7.1.3 Market Shares of Key Players
      • 7.7.1.4 Market Forecast
    • 7.7.2 Brazil Insulin Market
      • 7.7.2.1 Historical Market Trends
      • 7.7.2.2 Market Breakup by Class
      • 7.7.2.3 Market Shares of Key Players
      • 7.7.2.4 Market Forecast

8 Competitive Landscape

  • 8.1 Competitive Structure
  • 8.2 Profiles of Key Players
Back to Top